Creative Medical Technology Holdings, Inc. Common Stock vs. Twist Bioscience Corporation Common Stock
CELZ
Creative Medical Technology Holdings, Inc. Common Stock
$0.93 -3.17%
VS TWSTTwist Bioscience Corporation Common Stock
$193.24 +3.82%
Twist Bioscience Corporation Common Stock (TWST) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| CELZ | TWST | |
|---|---|---|
| Market Cap | $7.10 million | $12.34 billion |
| Revenue (TTM) | — | $431.80 million |
| Net Income (TTM) | — | $-136,717,000 |
TWST leads on 1 of 1 size & scale factors.
Valuation
| CELZ | TWST | |
|---|---|---|
| Price / Book | — | 27.69 |
| Price / Sales | — | 28.58 |
CELZ and TWST split the valuation factors evenly.
Profitability
| CELZ | TWST | |
|---|---|---|
| Net Margin | — | -31.66% |
| Return on Equity | — | -30.67% |
CELZ and TWST split the profitability factors evenly.
Risk & Sentiment
| CELZ | TWST | |
|---|---|---|
| Short Interest | 0.18% | 0.08% |
TWST leads on 1 of 1 risk & sentiment factors.
Dig deeper: CELZ overview, CELZ financials, TWST overview, TWST financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.